Quick Search

 

 


 

 

Result Summary for AK1A4006

Result Summary
Protocol ID: AK1A4006
Clinical Study ID: WELL AK1A4006
Official Title: A Multicenter, Double-Blind, Placebo-Controlled Comparison of the Safety and Efficacy and Effects on Sexual Functioning of Wellbutrin (Bupropion HCl) Sustained Release (SR) and Fluoxetine in Outpatients with Moderate to Severe Recurrent Major Depression
Phase: Phase 4
Study Indications or Diseases:
  • Depressive Disorder, Major
Generic Name: bupropion
Trade/Product Name: wellbutrin;zyban
Approved Drug Label: http://www.gsk.com/products.html
Results Summary: Click here to download result summary. Click here to download result summary.
Citations:

The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.